| Transvaginal Botulinum Toxin A for Interstitial Cystitis / Bladder Pain Syndrome (NCT05485207) | Stanford University | 2022-04-04 |
| Assessment of Urinary Polymerase Chain Reaction (PCR) and Next Generation Sequencing (NGS) Technology in the Evaluation and Management of Females With Chronic Bladder Pain and Cystitis-like Symptoms (NCT05276466) | MicroGenDX | 2022-02-01 |
| Biopsychosocial and Conventional Approach in Bladder Pain Syndrome (NCT05155384) | Hacettepe University | 2021-11-12 |
| GAG-therapy Efficacy Trial Solution for Bladder Pain Syndrome/ Interstitial Cystitis (GETSBI Study) (NCT05518864) | Radboud University Medical Center | 2021-10-21 |
| IC PaIN Trial: Interstitial Cystitis Pain Improvement With Naltrexone (NCT04313972) | Endeavor Health | 2021-09-07 |
| Motor Cortical Neuromodulation in Women With Interstitial Cystitis/Bladder Pain Syndrome (NCT04734847) | University of Southern California | 2021-06-01 |
| PEMF Therapy to Treat Interstitial Cystitis/Bladder Pain Syndrome (NCT04540887) | Wake Forest University Health Sciences | 2021-02-24 |
| The CBD-IC Randomized Controlled Trial: Evaluation of Hemp Cannabidiol SuppositoRies for Pain and Urinary SymptOms in INterstitial Cystitis (CHRONIC) (NCT04349930) | University of New Mexico | 2021-01-01 |
| Low-dose Naltrexone for Bladder Pain Syndrome (NCT04450316) | Stanford University | 2020-10-08 |
| The Female Microbiome in Patients Undergoing Bladder Instillation Therapy (NCT05414305) | Walter Reed National Military Medical Center | 2020-10-01 |
| Bladder Instillations Versus Onabotulinumtoxin A for Treatment of Interstitial Cystitis/Bladder Pain Syndrome (NCT04401176) | Walter Reed National Military Medical Center | 2020-09-15 |
| Optimizing Psychosocial Treatment of Interstitial Cystitis/Bladder Pain Syndrome (NCT04275297) | Vanderbilt University Medical Center | 2020-07-13 |
| PK and Safety of SI-722 in IC/BPS (NCT04208087) | Seikagaku Corporation | 2020-03-30 |
| Evaluation of Response to Use of Intravesical Ozone Gas in Interstitial Cystitis /Bladder Pain Syndrome (NCT04789135) | Anhembi Morumbi University | 2020-03-20 |
| Hypnosis for Bladder Pain Syndrome (NCT04010513) | University of Pennsylvania | 2019-10-03 |
| Translational Research in Pelvic Pain (NCT04001244) | University of Oxford | 2019-09-01 |
| Intravesical Injection of Dextrose to Improve Lower Urinary Tract Symptoms Caused by Chronic Cystitis (NCT04821882) | National Defense Medical Center, Taiwan | 2019-05-01 |
| Platelet Enriched Plasma for Treatment of Interstitial Cystitis (NCT04118946) | Mansoura University | 2019-03-20 |
| Clinical Trial Comparing Two Bladder Instillations for IC/BPS (NCT03463915) | Olivia Cardenas-Trowers, M.D. | 2019-01-25 |
| What is the Prevalence of Female Pelvic Floor Disorders in Minnesota? (NCT03536221) | University of Minnesota | 2018-08-01 |
| Physiotherapeutic Interventions Applied to the Bladder Pain Syndrome (NCT03755375) | University of Sao Paulo General Hospital | 2018-02-05 |
| Mirabegron for the Treatment of Pain Motivated Urinary Frequency and Urgency in Women (NCT02981459) | State University of New York at Buffalo | 2017-12-08 |
| A Study to Investigate Efficacy, Safety, Pharmacodynamics and Pharmacokinetics of ASP6294 in the Treatment of Female Subjects With Bladder Pain Syndrome/Interstitial Cystitis (NCT03282318) | Astellas Pharma Europe B.V. | 2017-09-28 |
| Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome (NCT02858453) | Aquinox Pharmaceuticals (Canada) Inc. | 2016-07-01 |
| Engage 24: Evaluation of the Safety and Effectiveness of URG101 in Subjects With Interstitial Cystitis/Bladder Pain Syndrome (NCT02591199) | Urigen | 2015-09-01 |
| Comparing the Effect of Fulguration Versus Fulguration and Hydrodistension in Interstitial Cystitis/Bladder Pain Syndrome (NCT03987594) | Yonsei University | 2015-08-01 |
| Comparison of the Treatment of Refractory Bladder Pain Syndrome With DMSO and DMSO With Botulinum Toxin A (NCT03103594) | University of Pennsylvania | 2015-08-01 |
| Comparative Study Suburothelial and Trigonal Botulinum Toxin A Injection in Treatment of Interstitial Cystitis (NCT03076762) | Buddhist Tzu Chi General Hospital | 2015-03-01 |
| Microbiome of Urologic Chronic Pelvic Pain Syndrome (NCT03027076) | Johns Hopkins University | 2013-11-01 |
| Efficacy and Safety of AQX-1125 in IC/BPS (NCT01882543) | Aquinox Pharmaceuticals (Canada) Inc. | 2013-06-01 |
| Chronic Bladder Pain Syndrome in Women: Can Doxycycline Help? A Prospective Study (NCT01879930) | Insel Gruppe AG, University Hospital Bern | 2012-11-01 |
| Comparison of the Efficacy Between Transurethral Coagulation and Transurethral Resection of Ulcer in Bladder Pain Syndrome Patients (NCT01963988) | Samsung Medical Center | 2012-06-01 |
| The Safety and Efficacy of Gefapixant (AF-219/MK-7264) in Female Participants With Interstitial Cystitis /Bladder Pain Syndrome (MK-7264-005) (NCT01569438) | Afferent Pharmaceuticals, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2012-04-13 |
| Efficacy Study of Pentosan Polysulfate Sodium,Hydrodistension and Combination Therapy for Bladder Pain Syndrome (NCT01895153) | Samsung Medical Center | 2012-04-01 |
| Study of URG101 in Painful Bladder Syndrome and Interstitial Cystitis (NCT00517868) | Urigen | 2007-08-28 |
| Identifying Genetic Causes of IC/BPS (NCT00389142) | Boston Children's Hospital | 2006-01-15 |
| Diagnosis of Bladder Pain Syndrome / Interstitial Cystitis (NCT03023241) | Cantonal Hospital, Frauenfeld | 2004-12-01 |